菸鹼酸 Niacin
C 2 D 1
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場:cautious
the totality of the scientific evidence no longer supports the conclusion that a drug-induced reduction in triglyceride levels and/or increase in HDL-cholesterol levels in statin-treated patients results in a reduction in the risk of cardiovascular events
來源 ↗ L4b · EU EFSA
立場:neutral
L4c · UK NHS
立場:cautious
Taking high doses of nicotinic acid supplements can cause skin flushes. Taking high doses for a long time could lead to liver damage. ... Taking 17mg or less of nicotinic acid supplements a day, or 500mg or less of nicotinamide supplements a day, is unlikely to cause any harm.
來源 ↗ L4d · TW TFDA / 衛福部
立場:neutral
菸鹼酸(包括菸鹼醯胺)屬第(八)類營養添加劑;用於錠狀、膠囊狀食品,每日食用限量以菸鹼素當量(N.E.)計不得超過 100 毫克。
來源 ↗ L4e · WHO
立場:neutral
Pellagra is treated with at least 300 mg of nicotinamide in oral divided doses daily for 3-4 weeks. Nicotinamide is recommended in preference to nicotinic acid (niacin) because it does not cause the flushing reaction.
來源 ↗ 市場與行銷 (L10)
L10a · TW Market Channels
綜合維生素B群,包含B1、B2、B3、B5、B12、B9,長效持續8小時
L10b · TW Legal Identity (TFDA)
菸鹼素每日攝取量上限為100毫克菸鹼素當量;含維生素或礦物質之口服藥品基準表中,菸鹼素每日量逾35毫克NE且宣稱療效者列為指示藥品
L10c · TW Community (PTT/Dcard/Mobile01)